305 related articles for article (PubMed ID: 31149644)
1. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.
Mukherjee P; Augur ZM; Li M; Hill C; Greenwood B; Domin MA; Kondakci G; Narain NR; Kiebish MA; Bronson RT; Arismendi-Morillo G; Chinopoulos C; Seyfried TN
Commun Biol; 2019; 2():200. PubMed ID: 31149644
[TBL] [Abstract][Full Text] [Related]
2. Metabolic therapy: a new paradigm for managing malignant brain cancer.
Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
[TBL] [Abstract][Full Text] [Related]
3. Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
Seyfried TN; Shelton L; Arismendi-Morillo G; Kalamian M; Elsakka A; Maroon J; Mukherjee P
Neurochem Res; 2019 Oct; 44(10):2392-2404. PubMed ID: 31025151
[TBL] [Abstract][Full Text] [Related]
4. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
Shelton LM; Huysentruyt LC; Seyfried TN
Int J Cancer; 2010 Nov; 127(10):2478-85. PubMed ID: 20473919
[TBL] [Abstract][Full Text] [Related]
5. Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma.
Augur ZM; Doyle CM; Li M; Mukherjee P; Seyfried TN
Front Nutr; 2018; 5():91. PubMed ID: 30349820
[No Abstract] [Full Text] [Related]
6. Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.
Rais R; Jančařík A; Tenora L; Nedelcovych M; Alt J; Englert J; Rojas C; Le A; Elgogary A; Tan J; Monincová L; Pate K; Adams R; Ferraris D; Powell J; Majer P; Slusher BS
J Med Chem; 2016 Sep; 59(18):8621-33. PubMed ID: 27560860
[TBL] [Abstract][Full Text] [Related]
7. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.
Seyfried TN; Sanderson TM; El-Abbadi MM; McGowan R; Mukherjee P
Br J Cancer; 2003 Oct; 89(7):1375-82. PubMed ID: 14520474
[TBL] [Abstract][Full Text] [Related]
8. Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse.
Shelton LM; Huysentruyt LC; Mukherjee P; Seyfried TN
ASN Neuro; 2010 Jul; 2(3):e00038. PubMed ID: 20664705
[TBL] [Abstract][Full Text] [Related]
9. L-asparaginase and 6-diazo-5-oxo-L-norleucine synergistically inhibit the growth of glioblastoma cells.
Ohba S; Hirose Y
J Neurooncol; 2020 Feb; 146(3):469-475. PubMed ID: 32020477
[TBL] [Abstract][Full Text] [Related]
10. [2,4-(13)C]β-hydroxybutyrate metabolism in astrocytes and C6 glioblastoma cells.
Eloqayli H; Melø TM; Haukvik A; Sonnewald U
Neurochem Res; 2011 Aug; 36(8):1566-73. PubMed ID: 21538079
[TBL] [Abstract][Full Text] [Related]
11. Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?
Seyfried TN; Marsh J; Shelton LM; Huysentruyt LC; Mukherjee P
Epilepsy Res; 2012 Jul; 100(3):310-26. PubMed ID: 21885251
[TBL] [Abstract][Full Text] [Related]
12. Metabolic management of microenvironment acidity in glioblastoma.
Seyfried TN; Arismendi-Morillo G; Zuccoli G; Lee DC; Duraj T; Elsakka AM; Maroon JC; Mukherjee P; Ta L; Shelton L; D'Agostino D; Kiebish M; Chinopoulos C
Front Oncol; 2022; 12():968351. PubMed ID: 36059707
[TBL] [Abstract][Full Text] [Related]
13. Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model.
Maeyama M; Tanaka K; Nishihara M; Irino Y; Shinohara M; Nagashima H; Tanaka H; Nakamizo S; Hashiguchi M; Fujita Y; Kohta M; Kohmura E; Sasayama T
Sci Rep; 2021 Jan; 11(1):79. PubMed ID: 33420169
[TBL] [Abstract][Full Text] [Related]
14. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
[No Abstract] [Full Text] [Related]
15. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
Tardito S; Oudin A; Ahmed SU; Fack F; Keunen O; Zheng L; Miletic H; Sakariassen PØ; Weinstock A; Wagner A; Lindsay SL; Hock AK; Barnett SC; Ruppin E; Mørkve SH; Lund-Johansen M; Chalmers AJ; Bjerkvig R; Niclou SP; Gottlieb E
Nat Cell Biol; 2015 Dec; 17(12):1556-68. PubMed ID: 26595383
[TBL] [Abstract][Full Text] [Related]
16. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy.
Maurer GD; Brucker DP; Bähr O; Harter PN; Hattingen E; Walenta S; Mueller-Klieser W; Steinbach JP; Rieger J
BMC Cancer; 2011 Jul; 11():315. PubMed ID: 21791085
[TBL] [Abstract][Full Text] [Related]
17. Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.
Wang SZ; Poore B; Alt J; Price A; Allen SJ; Hanaford AR; Kaur H; Orr BA; Slusher BS; Eberhart CG; Raabe EH; Rubens JA
Clin Cancer Res; 2019 Oct; 25(19):5925-5936. PubMed ID: 31300448
[TBL] [Abstract][Full Text] [Related]
18. Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets.
Seyfried TN; Kiebish M; Mukherjee P; Marsh J
Epilepsia; 2008 Nov; 49 Suppl 8():114-6. PubMed ID: 19049606
[TBL] [Abstract][Full Text] [Related]
19. Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice.
Bornebusch AB; Mason GF; Tonetto S; Damsgaard J; Gjedde A; Fink-Jensen A; Thomsen M
Psychopharmacology (Berl); 2021 Mar; 238(3):833-844. PubMed ID: 33410985
[TBL] [Abstract][Full Text] [Related]
20. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.
Zhou W; Mukherjee P; Kiebish MA; Markis WT; Mantis JG; Seyfried TN
Nutr Metab (Lond); 2007 Feb; 4():5. PubMed ID: 17313687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
